Skip to content
Search

Latest Stories

Coca-Cola recalls nearly 900 cases due to plastic contamination

The presence of foreign materials, such as plastic, in food or drink products can pose health risks

Coca-Cola Issues Recall for 900 Cases Due to Plastic Contamination

The recall is classified as a Class II event by the FDA

iStock

Reyes Coca-Cola Bottling, LLC, based in Milwaukee, Wisconsin, has initiated a recall of nearly 900 cases of Coca-Cola Original Taste due to potential contamination with plastic. The recall affects 864 12-pack cases of Coca-Cola, which were distributed to retailers in Illinois and Wisconsin. The recall was announced on 6th March 2025, and is currently still in progress, according to the Food and Drug Administration (FDA).

The recall is classified as a Class II event by the FDA, which means that while the risk of severe health consequences is considered low, consumers may still experience temporary or reversible adverse effects. Plastic contamination in beverages poses a number of risks, including the potential for choking, oral injuries, or gastrointestinal discomfort if consumed.


Details of the Coca-Cola recall

The specific product involved in this recall is Coca-Cola Original Taste, packaged in 12-ounce (355 mL) cans. These cans are sold in 12-pack cases, and each case can be identified by the product codes provided by the manufacturer.

The recalled Coca-Cola product has the following identifiers:

  • Product description: 12 Fl Oz. (355 mL) cans, packaged in 12-can packs
  • Can UPC: 0 49000-00634 6
  • 12-pack UPC: 0 49000-02890 4
  • Date code: SEP2925MDA
  • Time stamp: 1100–1253

The recall notice issued by Reyes Coca-Cola Bottling advises both consumers and businesses not to consume, sell, or distribute the recalled products. Those who may have purchased the affected Coca-Cola packs should check their inventory for the specific date code and time stamp. Anyone who finds they have the recalled product is urged to return it to the point of purchase or to dispose of it safely.

Consumer safety concerns

The presence of foreign materials, such as plastic, in food or drink products can pose health risks. In this case, the main concerns include the potential for choking or injury to the mouth or throat if plastic is ingested. While the recall is classified as a Class II event, which indicates that the chance of severe health issues is unlikely, it is still possible for consumers to experience minor health effects if the contaminated product is consumed.

Common symptoms that could arise from ingesting foreign materials like plastic include difficulty swallowing, discomfort in the throat or mouth, or, in more serious cases, gastrointestinal distress. If consumers experience any adverse reactions after consuming the recalled Coca-Cola product, they are advised to seek medical advice immediately.

What to do if you have the recalled product

Reyes Coca-Cola Bottling and the FDA have provided guidance for those who may have purchased the affected Coca-Cola packs. Consumers should avoid consuming the product and instead check the product's packaging for the date code "SEP2925MDA" and the time stamp between 1100 and 1253. If the affected product is identified, it should not be consumed or sold. Customers are encouraged to return the product to the retailer for a refund or safely dispose of it.

Businesses and retailers who have received the affected product are also advised to check their stock for the identified date code and remove any recalled Coca-Cola products from shelves. Retailers should refrain from selling or distributing the recalled Coca-Cola cans to consumers and contact Reyes Coca-Cola Bottling for instructions on how to handle the affected stock.

The Coca-Cola recall and its implications

This recall affects consumers in two US states, Illinois and Wisconsin, though it is important for consumers and businesses in nearby regions to remain vigilant. While the FDA has categorised this recall as Class II, meaning it poses a lower risk of serious health consequences, it still highlights the importance of product safety and quality control within the food and beverage industry.

Contamination with foreign materials, even non-toxic ones like plastic, can pose a danger to public health, particularly when it comes to widely consumed products such as Coca-Cola. This recall serves as a reminder for both manufacturers and consumers to be vigilant about potential safety concerns and to take swift action in the event of contamination.

The recall is expected to continue until all affected products have been removed from store shelves and from consumers' homes. Consumers are encouraged to keep an eye on any updates from the FDA or Coca-Cola regarding the recall, and to report any incidents related to the recalled product to the FDA’s reporting system.

Consumer action and safety measures

The Coca-Cola recall, which affects nearly 900 cases of Coca-Cola Original Taste due to potential plastic contamination, has raised concerns for consumers in Illinois and Wisconsin. While the risk of serious health outcomes is considered low, consumers are urged to check their purchases for the affected date code and time stamp, and to return or dispose of the product if it is identified.

Reyes Coca-Cola Bottling and the FDA are working to ensure the safety of consumers, and all those affected by the recall are advised to remain vigilant and follow the provided guidance. If any adverse effects are experienced after consuming the product, seeking medical attention is recommended.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less
Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images

Tennis champion Monica Seles reveals living with myasthenia gravis

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Keep ReadingShow less